Dynavax Technologies
DVAX
#4921
Rank
NZ$3.32 B
Marketcap
NZ$28.33
Share price
0.00%
Change (1 day)
13.09%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -NZ$63.57 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are NZ$0.33 Billion. In 2024 the company made an earning of NZ$68.82 Million, an increase over its 2023 earnings that were of NZ$4.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$63.57 Million-192.35%
2024 NZ$68.82 M1475.31%
2023 NZ$4.36 M-99.2%
2022 NZ$0.54 B238.78%
2021 NZ$0.16 B-257.89%
2020 -NZ$0.11 Billion-58.58%
2019 -NZ$0.25 Billion-9.32%
2018 -NZ$0.28 Billion60.44%
2017 -NZ$0.18 Billion-15.8%
2016 -NZ$0.21 Billion4.22%
2015 -NZ$0.2 Billion16.54%
2014 -NZ$0.17 Billion37.09%
2013 -NZ$0.13 Billion
2010 -NZ$87 Million214.85%
2009 -NZ$27.64 Million-37.33%
2008 -NZ$44.1 Million-66.07%
2007 -NZ$0.13 Billion16.92%
2006 -NZ$0.12 Billion170.36%
2005 -NZ$41.12 Million33.39%
2004 -NZ$30.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.73 B-20,661.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.20 B-32,713.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$0.81 B-1,413.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-NZ$4.64 Billion 7,374.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.28 B-19,938.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$27.58 B-44,626.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$13.07 B-21,212.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
NZ$0.27 B-545.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.23 B-3,711.90%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel